These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22189846

  • 1. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients.
    Yokohama A, Saitoh A, Nakahashi H, Mitsui T, Koiso H, Kim Y, Uchiumi H, Saitoh T, Handa H, Jimbo T, Murayama K, Sakura T, Murakami H, Karasawa M, Nojima Y, Tsukamoto N.
    Int J Hematol; 2012 Jan; 95(1):77-85. PubMed ID: 22189846
    [Abstract] [Full Text] [Related]

  • 2. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
    Hsi AC, Robirds DH, Luo J, Kreisel FH, Frater JL, Nguyen TT.
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [Abstract] [Full Text] [Related]

  • 3. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia.
    Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA.
    J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
    [Abstract] [Full Text] [Related]

  • 4. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia.
    Patil P, Cieslak A, Bernhart SH, Toprak UH, Wagener R, López C, Wiehle L, Bens S, Altmüller J, Franitza M, Scholz I, Jayne S, Ahearne MJ, Scheffold A, Jebaraj BMC, Schneider C, Costa D, Braun T, Schrader A, Campo E, Dyer MJS, Nürnberg P, Dürig J, Johansson P, Böttcher S, Schlesner M, Herling M, Stilgenbauer S, Macintyre E, Siebert R.
    Genes Chromosomes Cancer; 2020 Apr; 59(4):261-267. PubMed ID: 31677197
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X.
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [Abstract] [Full Text] [Related]

  • 6. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC.
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [Abstract] [Full Text] [Related]

  • 7. Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling.
    Oberbeck S, Schrader A, Warner K, Jungherz D, Crispatzu G, von Jan J, Chmielewski M, Ianevski A, Diebner HH, Mayer P, Kondo Ados A, Wahnschaffe L, Braun T, Müller TA, Wagle P, Bouska A, Neumann T, Pützer S, Varghese L, Pflug N, Thelen M, Makalowski J, Riet N, Göx HJM, Rappl G, Altmüller J, Kotrová M, Persigehl T, Hopfinger G, Hansmann ML, Schlößer H, Stilgenbauer S, Dürig J, Mougiakakos D, von Bergwelt-Baildon M, Roeder I, Hartmann S, Hallek M, Moriggl R, Brüggemann M, Aittokallio T, Iqbal J, Newrzela S, Abken H, Herling M.
    Blood; 2020 Dec 10; 136(24):2786-2802. PubMed ID: 33301031
    [Abstract] [Full Text] [Related]

  • 8. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene.
    Sun S, Fang W.
    Biomed Pharmacother; 2020 Jun 10; 126():110107. PubMed ID: 32247279
    [Abstract] [Full Text] [Related]

  • 9. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
    Hu Z, Li S, Medeiros LJ, Sun T.
    Hum Pathol; 2017 Jul 10; 65():175-179. PubMed ID: 28232160
    [Abstract] [Full Text] [Related]

  • 10. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition.
    Bug S, Dürig J, Oyen F, Klein-Hitpass L, Martin-Subero JI, Harder L, Baudis M, Arnold N, Kordes U, Dührsen U, Schneppenheim R, Siebert R.
    Cancer Genet Cytogenet; 2009 Jul 10; 192(1):44-7. PubMed ID: 19480937
    [Abstract] [Full Text] [Related]

  • 11. A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.
    Soulier J, Pierron G, Vecchione D, Garand R, Brizard F, Sigaux F, Stern MH, Aurias A.
    Genes Chromosomes Cancer; 2001 Jul 10; 31(3):248-54. PubMed ID: 11391795
    [Abstract] [Full Text] [Related]

  • 12. Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.
    Aggarwal N, Pongpruttipan T, Patel S, Bayerl MG, Alkan S, Nathwani B, Surti U, Kitahara S, Chinthammitr Y, Swerdlow SH.
    Am J Surg Pathol; 2015 Dec 10; 39(12):1679-87. PubMed ID: 26379148
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K.
    Eur J Haematol; 2017 May 10; 98(5):459-466. PubMed ID: 28129454
    [Abstract] [Full Text] [Related]

  • 14. Does a subset of mature T-cell leukemias with features akin to T-cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T-cell lymphoma, NOS in a leukemic phase?
    Gajzer DC, Chen X, Sabath DE, Poh C, Naresh KN.
    EJHaem; 2024 Aug 10; 5(4):900-904. PubMed ID: 39157608
    [Abstract] [Full Text] [Related]

  • 15. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia.
    López C, Bergmann AK, Paul U, Murga Penas EM, Nagel I, Betts MJ, Johansson P, Ritgen M, Baumann T, Aymerich M, Jayne S, Russell RB, Campo E, Dyer MJ, Dürig J, Siebert R.
    Br J Haematol; 2016 Apr 10; 173(2):265-73. PubMed ID: 26917488
    [Abstract] [Full Text] [Related]

  • 16. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
    Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, Jones D.
    Blood; 2008 Jan 01; 111(1):328-37. PubMed ID: 17890451
    [Abstract] [Full Text] [Related]

  • 17. A case of T cell prolymphocytic leukemia involving blast transformation.
    Ichikawa K, Noguchi M, Imai H, Sekiguchi Y, Wakabayashi M, Sawada T, Komatsu N.
    Int J Hematol; 2011 May 01; 93(5):667-672. PubMed ID: 21505955
    [Abstract] [Full Text] [Related]

  • 18. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
    Yamasaki S, Nitta H, Kondo E, Uchida N, Miyazaki T, Ishiyama K, Kiyota M, Matsuoka H, Ichinohe T, Fukuda T, Atsuta Y, Suzumiya J, Suzuki R.
    Ann Hematol; 2019 Sep 01; 98(9):2213-2220. PubMed ID: 31327025
    [Abstract] [Full Text] [Related]

  • 19. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
    Momose H, Kurita N, Nishikii H, Yusa N, Yokoyama K, Shimizu E, Imoto S, Nanmoku T, Maruyama Y, Sakamoto T, Yokoyama Y, Kato T, Matsuoka R, Obara N, Sakata-Yanagimoto M, Chiba S.
    Rinsho Ketsueki; 2024 Sep 01; 65(1):35-40. PubMed ID: 38311387
    [Abstract] [Full Text] [Related]

  • 20. Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.
    Schrader A, Crispatzu G, Oberbeck S, Mayer P, Pützer S, von Jan J, Vasyutina E, Warner K, Weit N, Pflug N, Braun T, Andersson EI, Yadav B, Riabinska A, Maurer B, Ventura Ferreira MS, Beier F, Altmüller J, Lanasa M, Herling CD, Haferlach T, Stilgenbauer S, Hopfinger G, Peifer M, Brümmendorf TH, Nürnberg P, Elenitoba-Johnson KSJ, Zha S, Hallek M, Moriggl R, Reinhardt HC, Stern MH, Mustjoki S, Newrzela S, Frommolt P, Herling M.
    Nat Commun; 2018 Feb 15; 9(1):697. PubMed ID: 29449575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.